Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding

References

• Keelan PC, Johnston JM, Koru-Sengul T, Detre KM, Williams DO, Slater J, . Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions < or = 40%, 41% to 49%, and >or = 50% having percutaneous coronary revascularization. Am J Cardiol. 2003;91:1168–72.
   Google Scholar
• Wallace TW, Berger JS, Wang A, Velazquez EJ, Brown DL. Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. AmJ Cardiol. 2009;103:355–60.
   Google Scholar
• Iliodromitis KE, Kahlert P, Plicht B, Hoffmann AC, Eggebrecht H, Erbel R, . High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support. Int J Cardiol. 2011;153:59–63.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, . Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2009;54:2430–4.
   PubMed Web of Science ®Google Scholar
• Dixon SR, Henriques JP, Mauri L,Sjauw K, Civitello A, Kar B, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91–6.
   PubMed Web of Science ®Google Scholar
• Brodie BR, Stuckey TD, Hansen C, Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999;84:18–23.
   Google Scholar
• Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, . Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608–12.
   Google Scholar
• Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, . Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97:990–2.
   PubMed Web of Science ®Google Scholar
• Mejia VM, Naidu SS, Hermann H, Textbook of Interventional Cardiology 5th Edition, Topol EJ, editor. Philadelphia, PA,USA: Saunders Elsevier; 2008. pp. 643–4.
   Google Scholar
• Raess DH, Weber DM. Impella 2.5. J Cardiovasc Trans Res. 2009;2:168–72.
   PubMed Web of Science ®Google Scholar
• Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation. 1982;66:593–97.
   PubMed Web of Science ®Google Scholar
• Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87:500–11.
   PubMedGoogle Scholar
• Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65:263–7.
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, . A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–8.
   PubMed Web of Science ®Google Scholar
• Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, . Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–83.
   PubMed Web of Science ®Google Scholar
• Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials. Eur Heart J. 2009;30:2102–8.
   PubMed Web of Science ®Google Scholar
• Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, . BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention a randomized controlled trial. JAMA. 2010;304:867–74.
   PubMed Web of Science ®Google Scholar